Filing Details
- Accession Number:
- 0001127602-14-000931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-03 17:25:25
- Reporting Period:
- 2014-01-02
- Filing Date:
- 2014-01-03
- Accepted Time:
- 2014-01-03 17:25:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236441 | A Robert Breyer | Connaught House 1 Burlington Road Dublin 4 Ireland | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-01-02 | 400 | $14.04 | 54,156 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2014-01-02 | 4,600 | $14.60 | 58,756 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-01-02 | 5,000 | $40.44 | 53,756 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2014-01-02 | 400 | $0.00 | 400 | $14.04 |
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2014-01-02 | 4,600 | $0.00 | 4,600 | $14.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-09-21 | No | 4 | M | Direct | |
| 20,400 | 2021-10-05 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- These options are fully vested in accordance with their terms.
Billionaire Hedge Funds
